Brian Baumann is an Oncology physician affiliated with Springfield Clinic. OpenAlex indexes 208 publications with 3,141 citations (h-index 32); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
301 N 8th St
Springfield, IL 627011041
Telephone
217-528-7541Provider last certified this registry record 1 May 2023.
Clinical trials
- SpaceIT Hydrogel System for Perirectal Spacing
Sponsor: Boston Scientific Corporation
- Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer
Sponsor: Varian, a Siemens Healthineers Company
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202517 payments
- Astellas Pharma US IncProgram year20254 payments
- Tactile Systems Technology IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
79.9%Gonadotropin Releasing Hormone Receptor Agonist68.2%Leuprolide acetate100%Part B, office-administered≥40 patientsAndrogen Receptor Inhibitor7.6%Bicalutamide100%Part D≥31 patients+ 1 more class in this area
Genitourinary & hormones
14.7%alpha-Adrenergic Blocker14.7%Tamsulosin Hcl100%Part D≥28 patientsAnti-infectives
3%First-generation cephalosporins3%Cephalexin100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
npj Precision Oncology
2023 - CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
Clinical and Translational Radiation Oncology
2023 - Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
Journal of Nuclear Medicine
2023 - A Projection-Domain Low-Count Quantitative SPECT Method for ɑ-Particle-Emitting Radiopharmaceutical Therapy
IEEE Transactions on Radiation and Plasma Medical Sciences
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Donald R. Graham
Springfield Clinic
Benjamin Fischer-Valuck, MD
Springfield Clinic
Rebecca Green, MD
Springfield Clinic
Bradford West, MD
Springfield Clinic
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”